RhumbLine Advisers’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-421,197
Closed -$77.4M 3059
2021
Q2
$77.4M Sell
421,197
-7,839
-2% -$1.44M 0.1% 169
2021
Q1
$65.6M Sell
429,036
-20,848
-5% -$3.19M 0.09% 198
2020
Q4
$70.3M Sell
449,884
-37,144
-8% -$5.8M 0.1% 173
2020
Q3
$55.7M Sell
487,028
-6,876
-1% -$787K 0.09% 198
2020
Q2
$55.4M Buy
493,904
+34,800
+8% +$3.91M 0.09% 187
2020
Q1
$41.2M Buy
459,104
+10,666
+2% +$958K 0.09% 209
2019
Q4
$48.5M Buy
448,438
+3,075
+0.7% +$333K 0.08% 220
2019
Q3
$43.6M Buy
445,363
+22,773
+5% +$2.23M 0.08% 237
2019
Q2
$55.4M Sell
422,590
-1,284
-0.3% -$168K 0.1% 188
2019
Q1
$57.3M Buy
423,874
+5,183
+1% +$701K 0.11% 171
2018
Q4
$40.8M Buy
418,691
+7,608
+2% +$741K 0.09% 208
2018
Q3
$57.1M Buy
411,083
+2,370
+0.6% +$329K 0.11% 184
2018
Q2
$50.7M Buy
408,713
+13,392
+3% +$1.66M 0.1% 195
2018
Q1
$44.1M Sell
395,321
-8,168
-2% -$910K 0.09% 222
2017
Q4
$48.3M Buy
403,489
+15,174
+4% +$1.81M 0.1% 211
2017
Q3
$54.5M Sell
388,315
-4,040
-1% -$567K 0.12% 181
2017
Q2
$47.7M Buy
392,355
+5,479
+1% +$667K 0.11% 196
2017
Q1
$46.9M Buy
386,876
+10,282
+3% +$1.25M 0.11% 193
2016
Q4
$46.1M Buy
376,594
+14,255
+4% +$1.74M 0.12% 184
2016
Q3
$44.4M Buy
362,339
+8,418
+2% +$1.03M 0.12% 172
2016
Q2
$41.3M Buy
353,921
+16,819
+5% +$1.96M 0.12% 170
2016
Q1
$46.9M Buy
337,102
+16,262
+5% +$2.26M 0.15% 136
2015
Q4
$61.2M Sell
320,840
-1,378
-0.4% -$263K 0.2% 102
2015
Q3
$50.4M Buy
322,218
+12,249
+4% +$1.92M 0.17% 121
2015
Q2
$56M Sell
309,969
-24,446
-7% -$4.42M 0.18% 113
2015
Q1
$58M Sell
334,415
-479
-0.1% -$83K 0.17% 126
2014
Q4
$62M Sell
334,894
-5,585
-2% -$1.03M 0.18% 119
2014
Q3
$56.5M Sell
340,479
-6,900
-2% -$1.14M 0.17% 127
2014
Q2
$54.3M Buy
347,379
+40,236
+13% +$6.29M 0.16% 145
2014
Q1
$46.7M Sell
307,143
-9,480
-3% -$1.44M 0.14% 161
2013
Q4
$42.1M Sell
316,623
-21,955
-6% -$2.92M 0.12% 169
2013
Q3
$39.3M Sell
338,578
-9,422
-3% -$1.09M 0.12% 170
2013
Q2
$32.1M Buy
+348,000
New +$32.1M 0.1% 188